Non-viral gene transfection technologies for genetic engineering of stem cells

被引:50
作者
Jo, Jun-Ichiro [1 ]
Tabata, Yasuhiko [1 ]
机构
[1] Kyoto Univ, Dept Biomat, Kyoto, Japan
关键词
non-viral gene carrier; genetic engineering; stem cells; drug delivery system; regenerative medical therapy;
D O I
10.1016/j.ejpb.2007.04.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The recent rapid progress of molecular biology together with the steady progress of genome projects has given us some essential and revolutionary information about DNA and RNA to elucidate various biological phenomena at a genetic level. Under these circumstances, the technology and methodology of gene transfection have become more and more important to enhance the efficacy of gene therapy for several diseases. In addition, gene transfection is a fundamental technology indispensable to the further research development of basic biology and medicine regarding stem cells. Stem cells genetically manipulated will enhance the therapeutic efficacy of cell transplantation. In this paper, the carrier and technology of gene delivery are briefly overviewed while the applications to the basic researches of biology and medicine as well as regenerative medical therapy are introduced. A new non-viral carrier and the cell culture system are described to efficiently manipulate stem cells. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 104
页数:15
相关论文
共 183 条
[51]   RETRACTED: Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran (Retracted article. See vol. 232, pg. 269, 2016) [J].
Hosseinkhani, H ;
Tabata, Y .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (2-3) :540-556
[52]   Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly( glycolic acid) fiber [J].
Hosseinkhani, H ;
Inatsugu, Y ;
Hiraoka, Y ;
Inoue, S ;
Tabata, Y .
TISSUE ENGINEERING, 2005, 11 (9-10) :1476-1488
[53]   Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells [J].
Hosseinkhani, H ;
Inatsugu, Y ;
Hiraoka, Y ;
Inoue, S ;
Shimokawa, H ;
Tabata, Y .
TISSUE ENGINEERING, 2005, 11 (9-10) :1459-1475
[54]   RETRACTED: PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin® (Retracted article. See vol. 232, pg. 270, 2016) [J].
Hosseinkhani, H ;
Tabata, Y .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (01) :157-171
[55]   RETRACTED: In vitro transfection of plasmid DNA by amine derivatives of gelatin accompanied with ultrasound irradiation (Retracted article. See vol. 37, 2020) [J].
Hosseinkhani, H ;
Aoyama, T ;
Yamamoto, S ;
Ogawa, O ;
Tabata, Y .
PHARMACEUTICAL RESEARCH, 2002, 19 (10) :1471-1479
[56]  
Hosseinkhani Hossein, 2003, Current Pharmaceutical Biotechnology, V4, P109, DOI 10.2174/1389201033489883
[57]   Liposomal gene delivery: A complex package [J].
Huang, L ;
Li, S .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :620-621
[58]   Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin [J].
Ito, M ;
Yamamoto, S ;
Nimura, K ;
Hiraoka, K ;
Tamai, K ;
Kaneda, Y .
JOURNAL OF GENE MEDICINE, 2005, 7 (08) :1044-1052
[59]   Controllable delivery of non-viral DNA from porous scaffolds [J].
Jang, JH ;
Shea, LD .
JOURNAL OF CONTROLLED RELEASE, 2003, 86 (01) :157-168
[60]   EXPRESSION OF A TRANSPOSABLE ANTIBIOTIC-RESISTANCE ELEMENT IN SACCHAROMYCES [J].
JIMENEZ, A ;
DAVIES, J .
NATURE, 1980, 287 (5785) :869-871